Table 1 Diagnostic value of Chemerin, CEA and CA15-3 for breast cancer patients.
From: The potential value of serum chemerin in patients with breast cancer
Variables | AUC | Cut off | Sensitivity (%) | Specificity (%) | 95% confidence interval | |
|---|---|---|---|---|---|---|
Upper limit | Lower limit | |||||
Chemerin | 0.703 | 100.327 | 56.60 | 98.10 | 0.767 | 0.642 |
CEA | 0.581 | 2.45 | 27.40 | 91.30 | 0.641 | 0.521 |
CA15-3 | 0.662 | 16.97 | 31.90 | 94.20 | 0.721 | 0.602 |
Chemerin + CEA | 0.768 | 59.70 | 97.10 | 0.815 | 0.720 | |
Chemerin + CA15-3 | 0.822 | 65.30 | 97.10 | 0.864 | 0.780 | |
CEA + CA15-3 | 0.691 | 39.90 | 92.20 | 0.748 | 0.634 | |
Chemerin + CEA + CA15-3 | 0.838 | 66.50 | 98.10 | 0.878 | 0.798 | |